Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Product Format Pre-filled injection pen Strength: 500 mg Supplied individually as one pen GHK-Cu Injection Pen Product Overview GHK-Cu Injection Pen is supplied as a pre-filled injection pen containing 500 mg
3 CELLULAR PROTECTION (82/100) Loaded with Chaga, Amalaki, and Reishi to fight systemic free radicals
Key Research Areas for 5-Amino-1MQ NNMT enzyme inhibition assays IC50 characterisation, selectivity profiling, and 1-MNA production quantification NAD+ salvage pathway studies nicotinamide flux, NMN and NAD+ pool modulation in vitro SAM/SAH methyl-donor pathway research epigenetic methylation capacity and histone modification studies Adipocyte biology lipogenesis suppression, adipocyte size, white adipose mass, and lipid storage pathway studies SIRT1 and SIRT3 activation and downstream pathway research insulin sensitivity, gluconeogenesis, mitochondrial function Skeletal muscle function and sarcopenia pathway research muscle strength, endurance, and mitophagy-related studies in aged models Gut microbiome modulation research in diet-induced obesity models Cancer cell biology NNMT-overexpressing cell line studies, anti-proliferative pathway investigations Cardiovascular metabolic pathway research homocysteine, SIRT activity, NF-B and STAT3 inflammatory signalling Comparative NNMT inhibitor studies 5-Amino-1MQ vs
Peptide mass: 10mg Bacteriostatic water: 2mL Concentration: 10mg 2mL = 5 mg/mL = 5,000 mcg/mL Peptide per unit (100-unit syringe): 5 mg 100 = 0.05 mg/unit = 50 mcg/unit If research protocol calls for 250 mcg per research unit: 250 mcg 50 mcg/unit = 5 units on the syringe Total doses per vial at 250 mcg each: 10,000 mcg 250 mcg = 40 research doses That single 10mg vial, reconstituted with 2mL of bacteriostatic water, provides 40 research doses of 250 mcg each, drawn to the 5-unit mark on a standard insulin syringe
EVX-101 and EVX-301 are being developed as drugs according to FDA guidance, would be approved for therapy by the FDA based controlled clinical trials, and would be manufactured and marketed as prescription (Rx) drugs under FDA supervision
